Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.

Journal of surgical oncology - 1 Dec 2017

Sho Shonan, Court Colin M, Winograd Paul, Russell Marcia M, Tomlinson James S

Abstract excerpt

BACKGROUND AND OBJECTIVES: Approximately 20-40% of stage II/III colorectal cancer (CRC) patients develop relapse. Clinicopathological factors alone are limited in detecting these patients, resulting in potential under/over-treatment. We sought to identify a prognostic tumor mutational profile that could predict CRC recurrence. METHODS: Whole-exome sequencing data were obtained for 207 patients with stage II/III...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Cohort Studies
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Formins

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Proportional Hazards Models

Share to Proto-Oncogene Proteins c-vav

Source

Identifiers

PMID: 28767131
DOI: 10.1002/jso.24781

Genes

APAF1
DIAPH2
NTNG1
USP7
VAV2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.PMID 28767131Read ↗

A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.Semantic proximity Read ↗

Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.Semantic proximity Read ↗

Cross-Cohort Evaluation of NanoString nCounter Data for Recurrence Prediction in Colorectal CancerSemantic proximity Read ↗

Genomic alterations associated with early-stage disease and early recurrence in patients with colorectal cancer.Semantic proximity Read ↗

Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancerSemantic proximity Read ↗

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal CancerSemantic proximity Read ↗

Prognostic whole-genome and transcriptome signatures in colorectal cancersSemantic proximity Read ↗

A network‐based predictive gene expression signature for recurrence risks in stage II colorectal cancerSemantic proximity Read ↗

The mutational factors influencing the therapeutic response and prognosis of stage IV CRC patients undergoing simultaneous resection of primary and liver metastatic lesions and subsequent adjuvant therapy---A pilot study on the prognosis of stage IV CRC.Semantic proximity Read ↗

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing.Semantic proximity Read ↗

Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study.Semantic proximity Read ↗

Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable OncogenesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.